Your fact-checks will appear here
US research institute, part of National Institutes of Health
Multiple major outlets report that the Trump administration enacted policies and budget proposals in 2025–2026 that reduced or threatened federal cancer-research funding — including proposals to cut t...
A comprehensive review of the available reporting shows no completed randomized, placebo‑controlled trials that prove ivermectin or mebendazole are effective cancer therapies; the literature instead c...
Major health authorities and recent journalism say there is no proven link between Bluetooth headphones and cancer; Bluetooth devices emit very low-power, non‑ionizing radiofrequency radiation (RFR), ...
Receptive anal intercourse is repeatedly identified in major medical reviews and public-health organizations as a behavior associated with increased risk of anal cancer because it raises exposure to o...
Federal reporting and advocacy documents say the Trump administration targeted hundreds to thousands of federally funded research awards, including cancer grants: reporting cites about $1–2.3 billion ...
Two registered early‑phase clinical trials combine ivermectin with immune checkpoint inhibitors for cancer: a phase I/II investigator‑initiated trial testing oral ivermectin with balstilimab (and an e...
Funding changes under the Trump administration included freezes, cancellations and proposed formula changes that advisers and researchers say removed or delayed “hundreds of millions” in cancer-relate...
The Trump administration’s early 2025 budget actions and policy changes led to large, specific reductions and program shifts at NIH and the National Cancer Institute (NCI): reporting and committee ana...
Available reporting shows multiple actions by the Trump administration and Congressional maneuvers in 2024–2025 that critics say reduced federal support for pediatric cancer research — including propo...
The claim that specific cancer research programs were “reduced or eliminated under Trump’s budget” is rooted in multiple reporting threads: a proposed 2026 federal budget that would cut the NIH by rou...
The U.S. recorded several distinct waves of COVID-19 deaths: roughly 384,536 deaths in 2020 and about 462,193 in 2021 according to year-by‑year counts drawn from CDC/MMWR compilations cited by Statist...
Large cohort studies and reviews link long‑term consumption of aspartame and acesulfame‑K to small but measurable increases in some cancer and cardiovascular risks, and experimental work suggests effe...
Sweet & Low and similar have been extensively studied with mixed findings: recent cohort and mechanistic studies link some low‑ and no‑calorie sweeteners to metabolic, cognitive, gut‑microbiota, and c...
Multiple news outlets, a Senate minority report and advocacy statements say the Trump administration paused, suspended or cut large amounts of federal biomedical funding in 2025 — with numbers frequen...
The Trump administration’s interventions at NIH led to the termination or freezing of hundreds to thousands of awards covering a wide swath of biomedical research, including cancer studies; independen...
Federal regulators have treated laetrile and amygdalin as unapproved, potentially dangerous products for decades: the FDA has never approved laetrile for any medical use and has repeatedly used warnin...
Major systematic reviews and expert bodies find no conclusive evidence that 5G-frequency radiofrequency (RF) fields, at exposure levels experienced by the public, cause cancer; WHO/IARC and national a...
Donald Trump did not found the National Cancer Moonshot Initiative; it originated under President Obama with Vice President Joe Biden and received major authorization in the 21st Century Cures Act, wh...
After radical prostatectomy, major guidelines and expert bodies expect PSA to fall to undetectable levels within weeks to a few months and use low numerical thresholds and serial rises to define bioch...
Two U.S.-registered trials testing ivermectin in cancer patients are identifiable in recent reporting: a Phase I/II study combining ivermectin with the PD‑1 agonist balstilimab for metastatic triple‑n...